BRIEF-Addex Therapeutics reports positive results of an mGlu5 receptor occupancy study
* Reports positive results of an mGlu5 receptor occupancy study with dipraglurant in healthy volunteers Source text for Eikon: Further company coverage: (Gdynia Newsroom)
No comments:
Post a Comment